This association is more frequent after anti-tumor necrosis factor alpha (TNFα) inhibitor therapy in patients with TAK, with increased risk up to 25 times induced by reactivation and dissemination of Mycobacterium TB from latent foci of infection [19]. The gene discussed is TNF; the disease is infection.